SANIONA AB NPV revenue for the last year amounted to 17.00 M SEK, the most of which — 16.84 M SEK — came from its highest performing source at the moment, Rare Diesease Patients Innovative Treatments, the year earlier bringing 15.28 M SEK. The greatest contribution to the revenue figure was made by Germany — last year it brought SANIONA AB NPV 8.72 M SEK.